thanks for posting the article. I don’t think CSL will have anything to be concerned about. I do think the article however is a hatchet job on Aegros. Interviewing so called experts who don’t have any clue as to the intimacy of the technology as they are using a different process entirely(Cohn) . The Aegros technology has evolved and testament to this is the additional hyper immune products they can derive from the plasma.
Aegros have some fantastic people (operations, R&d ,scientific advisory) with depth and I am confident this business will succeed.
I am a shareholder in Aegros
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$265.50 |
Change
1.550(0.59%) |
Mkt cap ! $128.5B | |||
| Open | High | Low | Value | Volume |
| $264.45 | $265.88 | $259.33 | $230.1M | 870.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 27 | $265.30 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $265.80 | 79 | 1 |
View Market Depth
| Last trade - 16.12pm 23/07/2025 (20 minute delay) ? |
| CSL (ASX) Chart |